Abstract：Objective To investigate the clinical application of cervix-uterine internal target volume (ITV) in volume-modulated arc therapy (VMAT) for cervical cancer under different bladder filling conditions, aiming to obtain more accurate planning target volume (PTV). Methods Sixty-two patients with cervical cancer receiving radiotherapy rather than surgery were selected and randomly divided into the study (n=31) and control groups (n=31). In the study group, individualized ITV, PTV and PTV margin were obtained under three bladder filling status by localization CT scan to compare the VMAT. The target area and organs at risk (OARs) within the target area were statistically compared between two groups. The target missing rate in CBCT, adverse events and short-term efficacy of radiotherapy were analyzed in two groups. Results There was no significant difference in the volume of target area and OARs in the target area between two groups (both P>0.05). In the study group, the target missing rate and target missing volume were significantly lower compared with those in the control group (both P<0.05). There was no significant difference in the incidence of acute radiation-induced adverse events between two groups (P>0.05). The 1-, 2-year overall survival and progress-free survival did not significantly differ between two groups (all P>0.05). One patient in the study group had uterine recurrence and 2 cases in the control group. Conclusion Application of individualized cervix-uterine ITV and PTV in definitive VMAT under different bladder filling conditions can improve the accuracy of target area contouring and improve the local control rate in cervical cancer patients.
Ma Jianping,Pan Wenyan,Xia Xinshe et al. Application of cervix-uterine ITV in volumetric modulated arc therapy for cervical cancer under different bladder filling status[J]. Chinese Journal of Radiation Oncology, 2020, 29(7): 535-539.
[1] Forrest J, Presutti J, Davidson M, et al. A dosimetric planning study comparing intensity-modulated radiotherapy with four-field conformal pelvic radiotherapy for the definitive treatment of cervical carcinoma[J]. Clin Oncol, 2012, 24(4):e63-e70. DOI:10.1016/j.clon.2011.06.008. [2] Wang Q, Lang J, Song Y, et al. Evaluation of intra-and interfraction movement of the cervix and the uterine body during intensity-modulated radiation therapy[J]. Int J Radiat Oncol Biol Phys, 2012, 84:S446. DOI:10.1016/j.ijrobp.2012.07.1181. [3] Hitoshi M, Takafumi T, Takuro A, et al. Predictive factors of uterine movement during definitive radiotherapy for cervical cancer[J]. J Radiat Res, 2016, 15(1):1-8. DOI:10.1093/jrr/rrw101. [4] Lim K, Small W, Portelance L, et al. Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy for the defifinitive treatment of cervix cancer[J]. Int J Radiat Oncol Biol Phys, 2011, 79(2):348-355. DOI:10.1016/j.ijrobp.2009.10.075. [5] Otter S, Hussein M, Why S, et al. The use of ultrasound bladder scanning in cervical IMRT to reduce variability of uterine motion[J]. Radiother Oncol, 2017, 123:S377. DOI:10.1016/S0167-8140(17)31156-8. [6] Khan A, Jensen LG, Sun S, et al. Optimized planning target volume for intact cervical cancer[J]. Int J Radiat Oncol Biol Phys, 2012, 83(5):1501-1505. DOI:10.1016/j.ijrobp.2011.10.027. [7] Bondar ml, Hoogeman MS, Mens JW, et al. Individualized nonadaptive and online-adaptive intensity-modulated radiotherapy treatment strategies for cervical cancer patients based on pretreatment acquired variable bladder filling computed tomography scans[J]. Int J Radiat Oncol Biol Phys, 2012, 83(5):1618-1623. DOI:10.1016/j.ijrobp.2011.10.011. [8] Heijkoop ST, Langerak TR, Quint S, et al. Clinical implementation of an online adaptive plan-of-the-day protocol for nonrigid motion management in locally advanced cervical cancer IMRT[J]. Int J Radiat Oncol Bio Phys, 2014, 90(3):673-679. DOI:10.1016/j.ijrobp.2014.06.046. [9] Seppenwoolde Y, Stock M, Buschmann M, et al. Impact of organ shape variations on margin concepts for cervix cancer ART[J]. Radiother Oncol, 2016, 8(4):1-6. DOI:10.1016/j.radonc.2016.08.004.
2020, Vol. 29 
